In: 50th Annual Convention of the American Association of Equine Practitioners, 2004, Denver,

Colorado, (Ed.). Publisher: American Association of Equine Practitioners, Lexington KY. Internet
Publisher: International Veterinary Information Service, Ithaca NY (www.ivis.org), 4-Dec-2004;
P1446.1204

New Perspectives on the Drugs Used to Produce Sedation, Analgesia, and

Familiarity with select anesthetic drugs and anesthetic techniques reduces the risks involved in using anesthesia. Changing
to new and unfamiliar anesthetic drugs and techniques must provide significant advantage over the familiar drugs and
methods. Alpha-2 agonist (xylazine, detomidine, medetomidine, and romifidine), benzodiazepine (diazepam and
midazolam) and dissociative (ketamine) drug combinations provide safe and effective anesthesia for short-term total IV
anesthesia (TIVA). Additionally, they can be administered by infusion as an adjunct to inhalant anesthesia.

1. Introduction
The pharmacologic basis of practical equine anesthesia is based on the same tenants of all general anesthesia practice (i.e.,
hypnosis, analgesia, and muscle relaxation) [1]. The necessity to manage or reduce the stress associated with anesthesia and
surgery that can have detrimental effects should also be added to this list [2]. Translation of these tenants to practical terms
implies that drugs used to produce equine anesthesia should produce effects that render the horse oblivious to surgical
stimulation (hypnosis), keep the horse free from pain (analgesia), and allow the horse to be easily positioned or
manipulated (muscle relaxation) to facilitate the surgical procedure. All of these things need to be accomplished without
fear of neurologic, cardiovascular, or respiratory consequences. The search for a single drug that produces all of these
effects without producing significant side effects has been replaced by attempts to find the "ideal" anesthetic cocktail.
Toward this goal, old and new drugs are being combined in an attempt to produce the "ideal" anesthetic state (Fig. 1).

Figure 1. Qualities of the "ideal" anesthetic. - To view this image in full size go to the IVIS website at
www.ivis.org . -

With the exception of alpha-2 agonists, there are virtually no drugs being developed or available for use in horses that are
not currently being used in humans. Trends in the pharmacologic practice of equine anesthesia have been and continue to
be based on new developments in the practice of human anesthesia. Without exception, drugs that are currently used to
produce hypnosis, analgesia, and muscle relaxation in humans have been investigated in horses with mixed results. The
major factors contributing to the differences in response stem from the horses’ unique anatomical and physiological
differences, behavioral considerations, and the routes, rates, and volumes of drug required to produce safe and effective
anesthesia in horses compared with humans. Ideal anesthesia in the horse requires that every horse receive a complete
physical examination and electrocardiogram. Additionally, horses should have blood drawn for a complete blood count
(CBC), total protein, and packed cell volume. The horse should be placed in a quiet and distraction-free environment that is
free of debris, equipment, and potentially hazardous objects. The horse’s temperament should be assessed, and
consideration should be given to the estimated time of surgery and anesthetic-induced recumbency to determine the need
for appropriate positioning and padding, particularly in field situations. The horse should be sedate, uninterested in its
surroundings, reluctant to move, and relatively undisturbed or oblivious to the environment, people, and noises. There is
little question that the single most effective family of drugs capable of producing the aforementioned effects in horses are
the alpha-2 agonists (xylazine, detomidine, medetomidine, and romifidine) [3-6]. In addition to sedation, analgesia, and
muscle relaxation, these drugs are noted for producing stupor and ataxia in many horses, necessitating care in the handling
and movement of some horses to avoid a startle or violent response. The choice and dose of alpha-2 agonist should be
tailored to the individual horse and the surgical procedure to be performed. Xylazine has a relatively rapid onset and time to
peak effect when administered intravenously; however, it has a comparatively short duration of action that may not last
long enough to influence the recovery period [4]. IV detomidine, by contrast, takes a longer time to produce peak effects,
and it usually produces a greater degree of sedation that lasts longer than xylazine [5]. Medetomidine produces identical
effects to detomidine, but it is effective for a shorter period of time. Romifidine produces effects more like those of
xylazine, but it is effective for a longer period of time [4,7]. The equine surgeon’s knowledge and clinical experience
should determine which alpha-2 agonists should be used and how it will be tailored to the individual horse and the
procedure being performed. However, this is not the general practice. Most equine surgical facilities and equine surgeons
get used to doing things one or two ways, and they anesthetize every horse in the same way. The advantage of this
approach is that all surgical personnel become familiar with the anesthetic techniques being used, including what to expect
from their administration and most importantly, what to do if something goes wrong. The disadvantage of this approach is
that the anesthetic plan (drugs) is not tailored to the horses stature (weight versus size), condition (athletic versus
sedentary), temperament (quiet versus anxious), or physical condition (healthy versus sick). Additionally, not all anesthetic
plans are "ideal" for all equine surgical situations. What then are the best anesthetic drugs and anesthetic techniques that
offer the safest and most effective anesthetic experience for horses?

2. Discussion
The safest anesthetic techniques for horses employ the use of potent sedative analgesics (xylazine and detomidine), muscle
relaxants (guaifenesin and diazepam) [8-11], dissociative anesthetics (ketamine), and inhalant anesthesia (isoflurane,
sevoflurane). Although thiobarbiturates (thiopental) have been traditionally used to induce and maintain anesthesia for
short surgical procedures, their use can no longer be recommended for this purpose because of the high incidence for
respiratory (hypoventilation and apnea), cardiovascular (tachycardia and hypotension), and other side effects (muscle
weakness, delirium, and local inflammatory response) [12]. Similar comments can be made when considering the use of
more recently developed hypnotics like etomidate and propofol. Only ketamine, and possibly tiletamine (tiletamine-
zolazepam [a]), show a high degree of cardiorespiratory safety. When combined with adequate sedation and muscle
relaxation (diazepam and midazolam), these new hypnotics produce excellent induction and recovery from anesthesia [13-
16]. Indeed, the combination and administration of an alpha-2 agonist-dissociative anesthetic peripherally acting muscle
relaxant (e.g., xylazine-diazepam-ketamine) to a properly sedated horse produces the most reproducible, predictable, and
uneventful induction and maintenance of anesthesia in horses. Therefore, it is the standard to which all other anesthetics
and anesthetic protocols should be compared (Table 1) [14]. Various analgesic drugs including butorphanol,
buprenorphine, and morphine or analgesic techniques including preemptive administration of a non-steroidal anti-
inflammatory drug (NSAID) like phenylbutazone and local infiltration with lidocaine or bupivacaine can be added to this
protocol to enhance analgesia and limit stress [17-21]. However, a great deal of research and clinical experience has yet to
be completed to identify the best drugs and procedures for pain control in horses [22,23]. Regardless, various anesthetic
protocols have been used to produce anesthesia lasting from minutes (field anesthesia) to hours with minimal to no side
effects [16]. However, there are concerns when administering injectable (IV) drugs to produce total IV anesthesia (TIVA)
for longer anesthetic procedures, such as the total drug load administered and the potential for drug accumulation, a
prolonged period for drug elimination, and the development of cumulative drug effects (prolonged weakness, ataxia, and/or
prolonged recovery). This problem is not new, and it was a major catalyst for the transition from injectable to inhalant
anesthetic techniques and the focus on the need to support arterial blood pressure with catecholamines (dobutamine; i.e.,
the ability to better control the depth, duration, and elimination of anesthesia at the expense of potentially producing
hypotension) [24,25]. Today, the best of both worlds can be obtained by judiciously combining TIVA with inhalant
anesthesia to limit the total injectable and inhalant anesthetic drug load. This will produce less cardiorespiratory depression,
allow for greater control of anesthetic depth, and enable a more controlled and uneventful recovery from anesthesia [9].
This approach is facilitated by the intraoperative and post-operative administration of various analgesic drugs including a
morphine-lidocaine-ketamine (MLK) drug combination with or without additional sedation (xylazine and/or detomidine).
The near future will witness a refinement of these techniques, and hopefully, the development of newer injectable
anesthetic drugs that possess good anesthetic qualities and minimize side effects.
 Table 1. TIVA Techniques for Horses.
Drug Combination Concentration (mg/ml) Infusion Dose
Xylazine 1 1 - 3 ml/kg/h
Guaifenesin 100 To effect
Ketamine * 2
Detomidine 0.02 1 - 3 ml/kg/h
Guaifenesin 100 To effect
Ketamine * 2
Medetomidine 0.02 1 - 3 ml/kg/h
Guaifenesin 100 To effect
Ketamine * 2
Romifidine 0.06 1 - 3 ml/kg/h
Guaifenesin 100 To effect
Ketamine * 2
Butorphanol (0.02 mg/kg) may be added to enhance analgesia.
*Ketamine (4 mg/ml) reduces infusion to 0.8 ml/kg/h. Ketamine is generally infused at
rates of 25 - 150 [µg]/kg/min after adequate muscle relaxation.

Footnote
a. Tiletamine-zolazepam, Telazol, Fort Dodge Animal Health, Fort Dodge, IA 50501.

References
1. Muir WW, Hubbell JAE, Gabel AA. Overview of equine chemical restraint. In: Muir WW, Hubbell JAE, eds. Equine
anesthesia: monitoring and emergency therapy. St. Louis: Mosby Year Book, 1991; 1-6.
2. Taylor PM. Equine stress responses to anaesthesia. Br J Anaesth 1989; 63:702-709.
3. England GC, Clarke KW. Alpha 2 adrenoceptor agonists in the horse-a review. Br Vet J 1996; 152:641-657.
4. England GC, Clarke KW, Goossens L. A comparison of the sedative effects of three alpha 2-adrenoceptor agonists
(romifidine, detomidine, and xylazine) in the horse. J Vet Pharmacol Ther 1992; 15:194-201.
5. Wagner AE, Muir WW, Hinchcliff KW. Cardiovascular effects of xylazine and detomidine in horses. Am J Vet Res
1991; 52:651-657.
6. Yamashita K, Muir WW, Tsubakishita S, et al. Clinical comparison of xylazine and medetomidine for premedication of
horses. J Am Vet Med Assoc 2002; 221:1144-1149.
7. Yamashita K, Tsubakishita S, Futaok S, et al. Cardiovascular effects of medetomidine, detomidine and xylazine in
horses. J Vet Med Sci 2000; 62:1025-1032.
8. Muir WW, Skarda RT, Milne DW. Evaluation of xylazine guaifenesin, and ketamine hydrochloride for restraint in
horses. Am J Vet Res 1978; 39:1274-1278.
9. Yamashita K, Muir WW, Tsubakishita S, et al. Infusion of guaifenesin, ketamine, and medetomidine in combination
with inhalation of sevoflurane versus inhalation of sevoflurane alone for anesthesia of horses. J Am Vet Med Assoc 2002;
221:1150-1155.
10. Taylor PM, Kirby JJ, Shrimpton DJ, et al. Cardiovascular effects of surgical castration during anaesthesia maintained
with halothane or infusion of detomidine, ketamine and guaifenesin in ponies. Equine Vet J 1998; 30:304-309.
11. Grosenbaugh DA, Muir WW. Cardiorespiratory effects of sevoflurane, isoflurane, and halothane anesthesia in horses.
Am J Vet Res 1998; 59:101-106.
12. Muir WW, Mason DE. Effects of diazepam, acepromazine, detomidine, and xylazine on thiamylal anesthesia in horses.
J Am Vet Med Assoc 1993; 203:1031-1038.
13. Luna SP, Taylor PM, Massone F. Midazolam and ketamine induction before halothane anaesthesia in ponies:
cardiorespiratory, endocrine and metabolic changes. J Vet Pharmacol Ther 1997; 20:153-159.
14. Muir WW, Skarda RT, Milne DW. Evaluation of xylazine and ketamine hydrochloride for anesthesia in horses. Am J
Vet Res 1977; 38:195-201.
15. Muir WW, Gadawski JE, Grosenbaugh DA. Cardiorespiratory effects of tiletamine/zolazepam-ketamine-detomidine
combination in horses. Am J Vet Res 1999; 60:770-774.
16. Muir WW, Lerche P, Robertson JT, et al. Comparison of four drug combinations for total intravenous anesthesia of
horses undergoing surgical removal of an abdominal testis. J Am Vet Med Assoc 2000; 217:869-873.
17. Johnson CB, Taylor PM, Young SS, et al. Postoperative analgesia using phenylbutazone, flunixin or carprofen in
horses. Vet Rec 1993; 133:336-338.
18. Kohn CW, Muir WW. Selected aspects of the clinical pharmacology of visceral analgesics and gut motility modifying
drugs in the horse. J Vet Int Med 1988; 2:85-91.
19. Muir WW, Skarda RT, Sheehan WC. Cardiopulmonary effects of narcotic agonists and a partial agonist in horses. Am J
Vet Res 1978; 39:1632-1635.
20. Muir WW, Skarda RT, Sheehan WC. Hemodynamic and respiratory effects of xylazine-morphine sulfate in horses. Am
J Vet Res 1979; 40:1417-1420.
21. Raekallio M, Taylor PM, Bennett RC. Preliminary investigations of pain and analgesia assessment in horses
administered phenylbutazone or placebo after arthroscopic surgery. Vet Surg 1997; 26:150-155.
22. Muir WW. Recognizing and treating pain in horses. In: Reed SM, Bayly WM, Sellon DC, eds. Equine internal
medicine, 2nd ed. Philadelphia: W. B. Saunders, 2004; 1529-1542.
23. Taylor PM, Pascoe PJ, Mama KR. Diagnosing and treating pain in the horse. Where are we today? Vet Clin North Am
[Equine Pract] 2002; 18:1-19.
24. Swanson CR, Muir WW. Dobutamine-induced augmentation of cardiac output does not enhance respiratory gas
exchange in anesthetized recumbent healthy horses. Am J Vet Res 1986; 47:1573-1576.
25. Swanson CR, Muir WW. Hemodynamic and respiratory responses in halothane-anesthetized horses exposed to positive
end-expiratory pressure alone and with dobutamine. Am J Vet Res 1988; 49:539-542.

This manuscript is reproduced in the IVIS website with the permission of the AAEP http://www.aaep.org
All rights reserved. This document is available on-line at www.ivis.org. Document No. P1446.1204.